(Q37787605)

English

Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?

scientific article published on September 15, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system? (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

infection of the central nervous system

0 references

highly active antiretroviral therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833583

11 July 2024

author name string

M. Vissers

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833583

11 July 2024

F. F. Stelma

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833583

11 July 2024

P. P. Koopmans

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833583

11 July 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1386653210003227?httpAccept=text/xml

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

https://api.elsevier.com/content/article/PII:S1386653210003227?httpAccept=text/plain

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Journal of Clinical Virology

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

231-238

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Updated research nosology for HIV-associated neurocognitive disorders

1

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Antiretroviral therapy and central nervous system HIV type 1 infection

2

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Impaired neurocognition in HIV-infected patients: antecedents and treatment

3

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy

4

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Brain viral burden in HIV infection.

5

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

The challenge of viral reservoirs in HIV-1 infection

8

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy

9

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Neurologic presentations of AIDS.

11

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Role of microglia in central nervous system infections

12

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?

13

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.

15

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

The Neuropathology of HIV/AIDS.

16

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV infection of the central nervous system: clinical features and neuropathogenesis

17

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Effects of antiretroviral therapy on cognitive impairment

18

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Treating AIDS dementia

20

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir

21

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy

22

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications

23

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility

24

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

25

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

26

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies

27

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Predominance of Distinct Viral Genotypes in Brain and Lymph Node Compartments of HIV-1-Infected Individuals

28

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease

29

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Distinct HIV-1 env Sequences Are Associated with Neurotropism and Neurovirulence

32

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Macrophage Tropism and Cytopathicity of HIV-1 Variants Isolated Sequentially from a Long-Term Survivor Infected with nef-Deleted Virus

33

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

34

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain

37

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

39

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes

40

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

41

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

43

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

44

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection?

45

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

46

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

47

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence

49

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

The neuropathogenesis of AIDS

50

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus

51

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways

53

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Chemokine receptors in the human brain and their relationship to HIV infection

54

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain

55

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

58

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons

60

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor

63

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro

65

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry

66

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells

67

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

68

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Genetic attributes of cerebrospinal fluid-derived HIV-1 env.

69

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

70

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues

71

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

72

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals

73

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Pharmacokinetics and bioavailability of zidovudine in humans

75

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

76

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples

77

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy

78

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

80

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

81

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV in the brain: RNA levels and patterns of zidovudine resistance

82

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy

84

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients.

85

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

86

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

87

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

88

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

89

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

91

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

92

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy

94

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment

95

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype

96

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma

97

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

98

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia

99

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence

100

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope.

101

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Apoptosis induced by HIV-1 infection of the central nervous system

102

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients

103

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4.

105

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia

106

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

107

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

108

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis

109

1 reference

10.1016/J.JCV.2010.08.001

https://api.crossref.org/works/10.1016/J.JCV.2010.08.001

11 July 2024

Identifiers

10.1016/J.JCV.2010.08.001

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37787605&oldid=2201267305"